Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...

New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...

PS-002, Purespring’s lead precision nephrology programme, targets the complement pathway known to be a driver of IgA ...

New stem cell therapy offers hope for type 1 diabetes, freeing patients from insulin. Learn why diverse clinical trial ...

Clinical Trials: What You Need to Know for Yourself, Your Family, and Your Community ...

In this video interview, Heather Horville, solutions consultant at Greenphire, discusses how growing financial and logistical ...

A patient shares how an event about clinical trials at Moores Cancer Center brought a community together to educate and ...

During Neuralink’s summer update on the trial, they showed the moment one participant was able to move a cursor with his ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD - ...

The chip has allowed the patient to wirelessly control a computer, as demonstrated by his ability to play video games using only his mind.